Obesity

SAN ANTONIO — In patients with obesity, the novel triple receptor agonist retatrutide was associated with improvement in health-related quality of life vs. placebo, a speaker reported.

BOSTON — Clinicians reviewing smartphone video clips of children sleeping often agreed on Monash Obstructive Sleep Apnea Video Scores, according to data presented at the CHEST Annual Meeting.

Obesity is more than just a number on a scale; it is a complex, chronic disease characterized by an excess of body fat that negatively impacts various aspects of health.

SAN ANTONIO — Tirzepatide demonstrated long-term weight-loss benefits and prevention of diabetes progression in patients with obesity and prediabetes, but only so long as they continued the weight-loss medication, a speaker reported.

SAN ANTONIO — In adolescents with obesity, GLP-1 receptor agonists were associated with lower risk for incident hypertension development 5 and 10 years after initiation vs. other anti-obesity medications, a speaker reported.

SAN ANTONIO —An intestinal microsomal triglyceride transfer protein inhibitor reduced postprandial triglycerides and halted weight gain in patients treated with the antipsychotic olanzapine, according to results of a pilot study.

SAN ANTONIO — Researchers identified several factors associated with likelihood of obesity drug prescription among youths, including female sex, higher obesity severity, having more comorbidities and older age, a speaker reported.

SAN ANTONIO — The disruptive SELECT trial not only bolstered the idea of medical obesity therapy as an avenue for heart disease prevention, its subanalyses continue to generate interesting new hypotheses, speakers reported.

Patients referred for percutaneous coronary intervention after acute myocardial infarction did not experience improved cardiovascular outcomes when taking colchicine compared with placebo, refuting previous study results.

SAN ANTONIO — Dysregulated amino and fatty acid metabolism during late pregnancy was tied to elevated incidence of type 2 diabetes among women with a history of gestational diabetes, according to a presentation at ObesityWeek.